StemSoft Software Launches New Corporate Website
The resource-focused website provides tools and information for the medical specialties.
Article
Two Industry Leaders Join Progenitor Cell Therapy Board
Progenitor Cell Therapy, LLC (PCT) announced today that Mr. Robert Hamm and Professor K.K. Jain have both agreed to join its Board of Managers and that a majority vote of the Members has formally approved both appointments.
Article
Aldagen, Inc. And Innovative Micro Technology Form Regenerative Medicine Alliance To Develop Revolutionary Stem Cell Purification System
Aldagen, Inc. and Innovative Micro Technology (IMT) today announced that they have formed an alliance to co-develop and commercialize a version of IMT’s Rare Cell Purification System, customized specifically for clinical cell therapies.
Article
Massachusetts Eye and Ear Infirmary (MEEI) To Evaluate Stem Cell Innovations’ PluriCells(TM) For Hearing Research
Under the material transfer agreement, MEEI will evaluate PluriCellsâ„¢ for their capacity to form the human tissues implicated in hearing loss. In return SCI will receive a nonexclusive license to intellectual property generated using the PluriCells.
Article
Healtheuniverse Announces Expansion of International Research and Development Center to Further Stem Cell Applications, Clinical Trials, and Product Line Commercialization
Healtheuniverse, Inc. has announced the incorporation of its new wholly owned subsidiary in Singapore, Healtheuniverse Pte Ltd.
Article
First Quantum Grant to Fund Stem Cell Repair of Damage from Stroke
The National Institutes of Health has named researchers at Baylor College of Medicine (BCM) and Rice University in Houston as the first and only recipients of the inaugural Quantum Grant for their international research initiative to regenerate damaged brain cells and blood vessels for the treatment of stroke.
Article
Stem Cell Products, Inc. Receives Grants from State of Wisconsin
Stem Cell Products, Inc. has announced that the Wisconsin Department of Commerce has awarded the company $1,000,000 in technology development grants and loans.
Article
DomaniCell Obtains Stem Cell Banking License
DomaniCell, LLC announced today it has obtained a license to perform umbilical cord blood collection, processing, and storage from the New Jersey Department of Health and Senior Services.
Article
MultiCell Technologies Announces Milestone Patent Issued by European Patent Office on Treatments for Autoimmune Diseases
This patent covers the company’s immune-based therapeutics to target MS, diabetes and other unmet medical needs.
Article
Lawsuits Allege Fraud and Negligence in Stem Cell Treatment
The Kansas City Blood and Marrow Transplant Program has been sued by 17 former patients and their survivors, who say the program failed to ensure stem cells given to patients were in good condition.
Article
Dead Cats to Remain a Memory
Genetic Savings & Clone, a biotechnology company that sold cloned pets, sent letters to its customers last month informing them it will close at the end of the year because of little demand for cloned cats.
Article